SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 199.20+0.1%Nov 21 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: lavalamp who wrote (10490)10/31/1997 11:04:00 AM
From: Phil Cressman  Read Replies (2) of 32384
 
RE: SRGN, Why buy the cow when the milk's so cheap. I've been most impressed with this thread and bought Ligand @ 16.50 for long term hold. SRGN is in real trouble financially and looking at their financials show why. High overhead and low research revenues last year plus a lot of shares outstanding and probably some very complicated arrangements with Boston U. If Ligand can get some proven (almost) technology from them through Lilly at a great price they would have to be crazy to take on the headache of buying and straightening out this company. If they bought it I would bet the shareholders might get a fraction of the current 56 cent trading price as the company just isn't worth it.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext